A biotechnology developer focused on antisense RNA therapies designed to treat rare and genetic diseases. Its platform targets disease-causing genes at the RNA level and has produced several partnered drugs and a broad clinical pipeline across neurology, cardiovascular, and metabolic disorders. Inve...
2 members of Congress have disclosed 2 trades in 449551 (ISIS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-05-27 | Thomas MacArthur | sell | $1K – $15K |
| 2014-09-18 | Sheldon Whitehouse | buy | $1K – $15K |